Integrated molecular and clinical analysis of BRAF-mutant glioma in adults
Abstract BRAF mutations are a significant driver of disease in pediatric low-grade glioma, but the implications of BRAF alterations on the clinical course and treatment response in adult glioma remain unclear. Here, we characterize a multi-institutional cohort of more than 300 patients (>200 adul...
Main Authors: | Karisa C. Schreck, Pinky Langat, Varun M. Bhave, Taibo Li, Eleanor Woodward, Christine A. Pratilas, Charles G. Eberhart, Wenya Linda Bi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-023-00359-y |
Similar Items
-
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors
by: Karisa C. Schreck, et al.
Published: (2019-08-01) -
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
by: Vasu Munjapara, et al.
Published: (2022-10-01) -
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
by: Benoit Lhermitte, et al.
Published: (2023-02-01) -
Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report
by: Gianluca Piccolo, et al.
Published: (2022-11-01) -
Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case
by: Christine Marlow, et al.
Published: (2023-03-01)